Insight Molecular Diagnostics (IMDX) Cash from Investing Activities Growth (5y) (2020 - 2026)
Insight Molecular Diagnostics (IMDX) Cash from Investing Activities Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn |
| 10 | Insight Molecular Diagnostics | 4.44 Mn | -24.49 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.57% |
| Dec 31, 2025 | -24.32% |
| Sep 30, 2025 | -14.83% |
| Jun 30, 2025 | 40.12% |
| Mar 31, 2025 | 45.16% |
| Dec 31, 2024 | 29.62% |
| Sep 30, 2024 | 62.17% |
| Jun 30, 2024 | -76.98% |
| Mar 31, 2024 | -20.21% |
| Sep 30, 2023 | 91.54% |
| Jun 30, 2023 | 55.99% |
| Mar 31, 2023 | -207.38% |
| Dec 31, 2022 | -166.20% |
| Sep 30, 2022 | -95.60% |
| Jun 30, 2022 | -37.11% |
| Mar 31, 2022 | -39.12% |
| Dec 31, 2021 | -30.00% |
| Sep 30, 2021 | -112.94% |
| Jun 30, 2021 | -151.13% |
| Mar 31, 2021 | -253.43% |